Status:
COMPLETED
Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation
Lead Sponsor:
Paris Translational Research Center for Organ Transplantation
Collaborating Sponsors:
Groupe Hospitalier Pitie-Salpetriere
European Georges Pompidou Hospital
Conditions:
Heart Transplantation
Allograft Arteriopathy
Eligibility:
All Genders
18+ years
Brief Summary
This project aims: i) to identify Cardiac Allograft Vasculopathy (CAV) trajectories after heat transplantation using latent class mixed modeling, ii) to characterize the global and specific determinan...
Detailed Description
Background: Cardiac Allograft Vasculopathy (CAV) is the third cause of late mortality and the leading cause of late allograft dysfunction. The field of heart transplantation currently lacks longitudi...
Eligibility Criteria
Inclusion
- Heart recipient with at least two coronary angiograms after heart transplantation,
- Heart recipient over 18 years of age.
Exclusion
- Patient with \< 2 coronary angiograms during follow-up
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT04117152
Start Date
January 1 2004
End Date
June 1 2020
Last Update
September 16 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Jon Kobashigawa
Los Angeles, California, United States, 90211
2
Maarten Naesens
Leuven, Belgium
3
Paris Transplant Group
Paris, France, 75015